Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Raw Materials (2016 - 2021)

Medifast (MED) has disclosed Raw Materials for 9 consecutive years, with $13.8 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Raw Materials rose 1.01% year-over-year to $13.8 million, compared with a TTM value of $13.8 million through Sep 2021, up 1.01%, and an annual FY2020 reading of $13.4 million, up 23.42% over the prior year.
  • Raw Materials was $13.8 million for Q3 2021 at Medifast, up from $9.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $13.8 million in Q3 2021 and bottomed at $4.3 million in Q3 2017.
  • Average Raw Materials over 5 years is $9.6 million, with a median of $10.5 million recorded in 2019.
  • The sharpest move saw Raw Materials dropped 27.71% in 2017, then surged 212.16% in 2018.
  • Year by year, Raw Materials stood at $4.3 million in 2017, then surged by 156.58% to $11.2 million in 2018, then dropped by 2.47% to $10.9 million in 2019, then increased by 23.42% to $13.4 million in 2020, then rose by 3.07% to $13.8 million in 2021.
  • Business Quant data shows Raw Materials for MED at $13.8 million in Q3 2021, $9.5 million in Q2 2021, and $11.2 million in Q1 2021.